These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency. Yuen KC, Dunger DB. Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975 [Abstract] [Full Text] [Related]
3. The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults. Yuen K, Cook D, Ong K, Chatelain P, Fryklund L, Gluckman P, Ranke MB, Rosenfeld R, Dunger D. Clin Endocrinol (Oxf); 2002 Sep; 57(3):333-41. PubMed ID: 12201825 [Abstract] [Full Text] [Related]
4. Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults. Yuen K, Frystyk J, Umpleby M, Fryklund L, Dunger D. J Clin Endocrinol Metab; 2004 Aug; 89(8):3956-64. PubMed ID: 15292333 [Abstract] [Full Text] [Related]
5. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. Laursen T, Jørgensen JO, Jakobsen G, Hansen BL, Christiansen JS. J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114 [Abstract] [Full Text] [Related]
7. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, Harris PE, Fryklund L, Murgatroyd PR, Dunger DB. Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235 [Abstract] [Full Text] [Related]
8. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. Dall R, Longobardi S, Ehrnborg C, Keay N, Rosén T, Jørgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sönksen PH. J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453 [Abstract] [Full Text] [Related]
9. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. Bang P, Brismar K, Rosenfeld RG, Hall K. J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573 [Abstract] [Full Text] [Related]
10. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. de Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E. J Clin Endocrinol Metab; 1996 Apr; 81(4):1371-7. PubMed ID: 8636336 [Abstract] [Full Text] [Related]
11. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance. Bülow B, Erfurth EM. Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855 [Abstract] [Full Text] [Related]
13. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G. Horm Res; 2005 Jan; 64(2):68-76. PubMed ID: 16113581 [Abstract] [Full Text] [Related]
14. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG. J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049 [Abstract] [Full Text] [Related]
17. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months. McConnell EM, Atkinson AB, Ennis C, Hadden DR, McCance DR, Sheridan B, Bell PM. J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703 [Abstract] [Full Text] [Related]
18. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, Rossetto R, Wu Z, Strasburger CJ, Ghigo E. Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509 [Abstract] [Full Text] [Related]
19. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism. Wilson ME. J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485 [Abstract] [Full Text] [Related]
20. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Khorram O, Laughlin GA, Yen SS. J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]